Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) Gross Margin (2017 - 2025)

Historic Gross Margin for Catheter Precision (VTAK) over the last 9 years, with Q3 2025 value amounting to 92.04%.

  • Catheter Precision's Gross Margin rose 24500.0% to 92.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 92.6%, marking a year-over-year increase of 21300.0%. This contributed to the annual value of 90.0% for FY2024, which is 32100.0% down from last year.
  • Latest data reveals that Catheter Precision reported Gross Margin of 92.04% as of Q3 2025, which was up 24500.0% from 93.4% recorded in Q2 2025.
  • Catheter Precision's 5-year Gross Margin high stood at 95.49% for Q3 2023, and its period low was 11075.0% during Q1 2021.
  • In the last 5 years, Catheter Precision's Gross Margin had a median value of 89.58% in 2024 and averaged 1740.04%.
  • As far as peak fluctuations go, Catheter Precision's Gross Margin tumbled by -110597200bps in 2021, and later surged by 101194400bps in 2022.
  • Catheter Precision's Gross Margin (Quarter) stood at 6840.0% in 2021, then soared by 82bps to 1220.0% in 2022, then soared by 108bps to 94.53% in 2023, then fell by -2bps to 92.62% in 2024, then dropped by -1bps to 92.04% in 2025.
  • Its last three reported values are 92.04% in Q3 2025, 93.4% for Q2 2025, and 92.31% during Q1 2025.